In this task, you are given a passage which has a question and the context. You have to generate an answer to the question based on the information present in the context.

[Q]: Context: Halofuginone is a novel antifibrotic agent that can reverse the fibrotic process by specific inhibition of collagen type I synthesis.', 'To evaluate the effect of Halo on the development of glomerulosclerosis and interstitial fibrosis in the 5/6 nephrectomy rat model', 'Male Wistar rats were assigned to undergo 5/6 NX or sham operation, and then divided into three groups: 5/6 NX rats (NX-Halo and NX-Control) and sham. Systolic blood pressure, proteinuria and body weight were determined every 2 weeks. At sacrifice (10 weeks) creatinine clearance was evaluated and remnant kidneys removed for histologic examination, sirius red staining and in situ hybridization', 'Systolic blood pressure increased progressively in both 5/6 NX groups. Halo slowed the increase in proteinuria in 5/6 NX rats. As expected, creatinine clearance was lower in 5/6 NX groups when compared to sham rats. Creatinine clearance was significantly higher in the NX-Halo group at the end of the study period. Histologic examination by light microscopy showed significantly less severe interstitial fibrosis and glomerulosclerosis in Halo-treated rats. The increase in collagen alpha1 (I) gene expression and collagen staining after nephrectomy was almost completely abolished by Halo.\Question: Does halofuginone reduce the occurrence of renal fibrosis in 5/6 nephrectomized rats?
[A]: Halofuginone reduced proteinuria as well as the severity of interstitial fibrosis and glomerulosclerosis in 5/6 NX rats. The renal beneficial effect of Halo was also demonstrated by the blunted decrease in creatinine clearance observed in the treated animals.


[Q]: Context: HIV-1-infected and/or immune-activated microglia and macrophages are pivotal in the pathogenesis of HIV-1-associated neurocognitive disorders (HAND). Glutaminase, a metabolic enzyme that facilitates glutamate generation, is upregulated and may play a pathogenic role in HAND. Our previous studies have demonstrated that glutaminase is released to the extracellular fluid during HIV-1 infection and neuroinflammation. However, key molecular mechanisms that regulate glutaminase release remain unknown. Recent advances in understanding intercellular trafficking have identified microvesicles (MVs) as a novel means of shedding cellular contents. We posit that during HIV-1 infection and immune activation, microvesicles may mediate glutaminase release, generating excessive and neurotoxic levels of glutamate.', 'MVs isolated through differential centrifugation from cell-free supernatants of monocyte-derived macrophages (MDM) and BV2 microglia cell lines were first confirmed in electron microscopy and immunoblotting. As expected, we found elevated number of MVs, glutaminase immunoreactivities, as well as glutaminase enzyme activity in the supernatants of HIV-1 infected MDM and lipopolysaccharide (LPS)-activated microglia when compared with controls. The elevated glutaminase was blocked by GW4869, a neutral sphingomyelinase inhibitor known to inhibit MVs release, suggesting a critical role of MVs in mediating glutaminase release. More importantly, MVs from HIV-1-infected MDM and LPS-activated microglia induced significant neuronal injury in rat cortical neuron cultures. The MV neurotoxicity was blocked by a glutaminase inhibitor or GW4869, suggesting that the neurotoxic potential of HIV-1-infected MDM and LPS-activated microglia is dependent on the glutaminase-containing MVs.\Question: Do glutaminase-containing microvesicles from HIV-1-infected macrophages and immune-activated microglia induce neurotoxicity?
[A]: These findings support MVs as a potential pathway/mechanism of excessive glutamate generation and neurotoxicity in HAND and therefore MVs may serve as a novel therapeutic target.


[Q]: Context: The objectives of this study were to obtain in-depth qualitative data from patients on the effect of edentulousness and prosthetic rehabilitation upon issues surrounding eating (emotional, social and functional).', '33 patients who had received replacement conventional dentures (CDs) and 33 patients who had received implant-supported mandibular overdentures (ISODs) were interviewed by a researcher outside the clinical team. Interviews focused upon their experience of edentulousness, its management and its impact on their lives. Interviews were transcribed and the qualitative data analysed using NVivo [QSR NVivo v.2.2. Melbourne: QSR International; 2002].', "Both groups of patients told similar stories about the impact of edentulousness upon eating. A few patients who had received replacement CDs reported significant improvement, but marginal improvements were more common. Most patients who had received ISODs reported a significant positive impact upon eating with very few negative effects reported. The findings suggest that the functional limitations of dentures often impose social restrictions on edentulous patients. Optimising conventional dentures may help, but patients' eating-related quality of life is most likely to be enhanced through the functional improvement and increased social confidence that ISODs bring.\Question: Do a qualitative study on patient perspectives of how conventional and implant-supported dentures affect eating?
[A]:
In conclusion, issues surrounding eating are a major concern for edentulous patients. The main impacts of edentulousness are limitation of social participation and food choice. The functional improvement and increased social confidence that ISODs can provide, has a beneficial impact on this aspect of patients of quality of life.